Neogen Chemicals Limited — Investor Meet, 18-02-2026: Analysts/Institutional Investor Meet/Con. Call Updates

Neogen Chemicals reported Q3 FY26 revenue of INR 220 crore (+9% YoY), with gross profit up 13%. EBITDA (INR 32 crore) and PAT (INR 4 crore) were impacted by ramp-up costs for Neogen Ionics, fire-related operational expenses, and higher finance costs. These are transient, with INR 251.12 crore net insurance claims receivable. The Dahej replacement plant commissioning is on track for Q1 FY27.

The company formed a JV with Japan's Morita for LiPF6 salt, with Neogen holding 80% and Morita investing approximately INR 166 crore for a 20% stake. This establishment is India's only plant with proven technology for non-FEOC compliant electrolyte salt. Pakhajan electrolyte production is targeted for H1 FY27, with salts in H2 FY27. Management reiterated FY27 battery chemicals revenue guidance of INR 400-500 crore. Total fund inflows of approximately INR 550 crore (insurance, Morita, promoter preferential issue) are expected by Q1 FY27, enhancing financial flexibility. The base business anticipates double-digit growth in FY27. Sentiment remains confident regarding strategic execution and future growth.